TIAA CREF Investment Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $4.85M | Buy |
91,715
+1,563
| +2% | +$82.7K | ﹤0.01% | 1468 |
|
|
2018
Q4 | $3.7M | Sell |
90,152
-3,800
| -4% | -$156K | ﹤0.01% | 1570 |
|
|
2018
Q3 | $3.57M | Sell |
93,952
-8,477
| -8% | -$322K | ﹤0.01% | 1807 |
|
|
2018
Q2 | $4.63M | Buy |
102,429
+9,567
| +10% | +$432K | ﹤0.01% | 1651 |
|
|
2018
Q1 | $4.49M | Buy |
92,862
+2,751
| +3% | +$133K | ﹤0.01% | 1615 |
|
|
2017
Q4 | $3.55M | Sell |
90,111
-35,962
| -29% | -$1.42M | ﹤0.01% | 1819 |
|
|
2017
Q3 | $3.92M | Sell |
126,073
-128,972
| -51% | -$4.01M | ﹤0.01% | 1774 |
|
|
2017
Q2 | $6.98M | Buy |
255,045
+124,439
| +95% | +$3.4M | ﹤0.01% | 1366 |
|
|
2017
Q1 | $4.81M | Buy |
130,606
+37,672
| +41% | +$1.39M | ﹤0.01% | 1618 |
|
|
2016
Q4 | $1.34M | Buy |
92,934
+30,283
| +48% | +$438K | ﹤0.01% | 2387 |
|
|
2016
Q3 | $1.44K | Buy |
62,651
+17,890
| +40% | +$412 | ﹤0.01% | 2350 |
|
|
2016
Q2 | $743K | Buy |
44,761
+22,748
| +103% | +$378K | ﹤0.01% | 2671 |
|
|
2016
Q1 | $349K | Sell |
22,013
-9,402
| -30% | -$149K | ﹤0.01% | 2884 |
|
|
2015
Q4 | $1.02M | Buy |
31,415
+10,810
| +52% | +$350K | ﹤0.01% | 2569 |
|
|
2015
Q3 | $869K | Buy |
+20,605
| New | +$869K | ﹤0.01% | 2647 |
|